EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy

Ioannis Vouloagkas, Andrea Agbariah, Thomas Zegkos, Thomas D Gossios iD, Georgios Tziomalos, Despoina Parcharidou, Matthaios Didagelos, Vasileios Kamperidis, Antonios Ziakas, Georgios K Efthimiadis

Heart Failure Reviews · 28.10.2024 · 30 (1) · 247-256

DOI: 10.1007/s10741-024-10459-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 28.10.2024. Verfasst von Ioannis Vouloagkas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cantonal Hospital of Winterthur, Winterthur, Switzerland. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Cardiomyopathies, Channelopathies, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SCN5A gene encodes the alpha subunit of the cardiac sodium channel, which plays a fundamental role in the generation and propagation of the action potential in the heart muscle. During the past years our knowledge concerning the function of the cardiac sodium channel and the diseases caused by mutations of the SCN5A gene has grown. Although initially SCN5A pathogenic variants were mainly associated with channelopathies, increasing recent evidence suggests an association with structural heart disease in the form of heart muscle disease. The pathways leading to a cardiomyopathic phenotype remain unclear and require further elucidation. The aim of the present review is to provide a concise summary regarding the mechanisms through which SCN5A pathogenic variants result in heart disease, focusing in cardiomyopathy, highlighting along the way the complex role of the SCN5A gene at the intersection of cardiac excitability and contraction networks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.5 Voltage-Gated Sodium ChannelCardiomyopathiesChannelopathiesMutationHumansPhenotype

Stichwörter der Autor:innen

Cardiac sodium channelCardiomyopathyChannelopathySCN5A gene

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, human

Autor:innen und Institutionen

  • Department of Medicine, Cantonal Hospital of Winterthur, Winterthur, Switzerland.
  • Department of Cardiology, Università Degli Studi Di Verona, Verona, Italy.
  • Cardiomyopathies Laboratory, 1st Aristotle University of Thessaloniki Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.
  • Cardiomyopathies Laboratory, 1st Aristotle University of Thessaloniki Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece. thomasgossios@hotmail.com.
  • 1st Aristotle University of Thessaloniki Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece.

ORCID-Profile: Thomas D Gossios

Zitieren

APA

Vouloagkas, I., Agbariah, A., Zegkos, T., Gossios, T. D., Tziomalos, G., Parcharidou, D., Didagelos, M., Kamperidis, V., Ziakas, A., & Efthimiadis, G. K. (2024). The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy. Heart Failure Reviews, 30(1), 247-256. https://doi.org/10.1007/s10741-024-10459-x

Vancouver

Vouloagkas I, Agbariah A, Zegkos T, Gossios TD, Tziomalos G, Parcharidou D, et al. The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy. Heart Failure Reviews. 2024;30(1):247-256. doi:10.1007/s10741-024-10459-x

BibTeX
@article{Vouloagkas2024,
  author = {Vouloagkas, Ioannis and Agbariah, Andrea and Zegkos, Thomas and Gossios, Thomas D and Tziomalos, Georgios and Parcharidou, Despoina and Didagelos, Matthaios and Kamperidis, Vasileios and Ziakas, Antonios and Efthimiadis, Georgios K},
  title = {The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy},
  journal = {Heart Failure Reviews},
  year = {2024},
  volume = {30},
  number = {1},
  pages = {247--256},
  doi = {10.1007/s10741-024-10459-x}
}
Kostenlos starten →